XENE vs ORA

Comparison between Xenon Pharmaceuticals Inc (XENE, Company) and Ormat Technologies Inc (ORA, Company).

XENE is from the Healthcare sector, while ORA is from the Utilities sector.

5-Year PerformanceXENE has outperformed ORA, delivering a return of +29.0% compared to +9.2%

XENE vs ORA - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	XENE(COMPANY)	ORA(COMPANY)
Market Cap	$6.39B	$6.38B
Max Drawdown	90.43%	74.68%
Sharpe Ratio	1.41	0.49
5Y Beta	0.93	0.59
Industry	Biotechnology	Utilities - Renewable
P/E Ratio	-14.22	49.60
Forward P/E	N/A	54.64
PEG Ratio	-0.35	56.40
Dividend Yield	N/A	0.46%
5Y Dividends CAGR	N/A	1.03%
5Y EPS CAGR	40.27%	8.35%
Debt to Equity	0.00%	0.00%
Free Cash Flow Yield	-4.80%	-3.38%
P/S Ratio	727.44	5.48
P/B Ratio	4.82	2.51

Market Cap

Winner

XENE

$6.39B

ORA

$6.38B

Max Drawdown

XENE

90.43%

Winner

ORA

74.68%

Sharpe Ratio

Winner

XENE

1.41

ORA

0.49

5Y Beta

XENE

0.93

Winner

ORA

0.59

Industry

XENE

Biotechnology

ORA

Utilities - Renewable

P/E Ratio

Winner

XENE

-14.22

ORA

49.60

Forward P/E

XENE

N/A

ORA

54.64

PEG Ratio

Winner

XENE

-0.35

ORA

56.40

Dividend Yield

XENE

N/A

ORA

0.46%

5Y Dividends CAGR

XENE

N/A

ORA

1.03%

5Y EPS CAGR

Winner

XENE

40.27%

ORA

8.35%

Debt to Equity

XENE

0.00%

ORA

0.00%

Free Cash Flow Yield

XENE

-4.80%

Winner

ORA

-3.38%

P/S Ratio

XENE

727.44

Winner

ORA

5.48

P/B Ratio

XENE

4.82

Winner

ORA

2.51

XENE vs ORA - Historical Returns

Returns include dividend reinvestment.

Period	XENE	ORA
1 month	+19.79%	-15.78%
3 months	+18.07%	-8.51%
6 months	+56.66%	-15.70%
1 year	+109.75%	+15.36%
5 years(CAGR)	+29.02%	+9.22%
10 years(CAGR)	+24.43%	+9.45%
Max(CAGR)	+16.91%	+9.83%

Winner

XENE

+19.79%

ORA

-15.78%

Winner

XENE

+18.07%

ORA

-8.51%

Winner

XENE

+56.66%

ORA

-15.70%

Winner

XENE

+109.75%

ORA

+15.36%

5Y(CAGR)

Winner

XENE

+29.02%

ORA

+9.22%

10Y(CAGR)

Winner

XENE

+24.43%

ORA

+9.45%

Max(CAGR)

Winner

XENE

+16.91%

ORA

+9.83%

XENE vs ORA - Annual Returns (2004 - 2026)

Returns include dividend reinvestment.

Year	XENE	ORA
2026	+47.04%	-8.51%
2025	+11.58%	+60.72%
2024	-12.71%	-10.80%
2023	+23.62%	-10.33%
2022	+24.82%	+10.72%
2021	+111.94%	-12.87%
2020	+12.10%	+21.35%
2019	+96.26%	+45.09%
2018	+119.48%	-18.37%
2017	-64.01%	+22.06%
2016	-3.27%	+54.41%
2015	-57.01%	+33.89%
2014	+88.10%	+1.51%
2013	N/A	+35.94%
2012	N/A	+5.14%
2011	N/A	-38.44%
2010	N/A	-21.16%
2009	N/A	+19.09%
2008	N/A	-41.19%
2007	N/A	+48.48%
2006	N/A	+32.17%
2005	N/A	+68.77%
2004	N/A	+3.89%

XENE vs ORA Drawdown Comparison

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The maximum drawdown for ORA was -73.97%, occurring on Sep 22, 2011. Recovery took 2267 trading sessions.

The current XENE drawdown is -7.81%. The current ORA drawdown is -28.44%.

Rank	XENE	ORA
#1	-90.43% Jan 8, 2015 - Oct 4, 2021	-73.97% Dec 28, 2007 - Dec 29, 2016
#2	-43.59% Feb 9, 2024 - Mar 9, 2026	-52.40% Feb 10, 2021 - Jan 22, 2026
#3	-34.08% May 9, 2023 - Dec 22, 2023	-36.16% Feb 19, 2020 - Dec 18, 2020
#4	-30.14% Nov 5, 2021 - Aug 4, 2022	-28.78% Jan 31, 2018 - Aug 8, 2019
#5	-25.87% Nov 11, 2014 - Dec 11, 2014	-28.63% Jun 3, 2026 - Jul 20, 2026
#6	-18.40% Mar 9, 2026 - Jul 7, 2026	-27.00% Feb 14, 2006 - Feb 9, 2007
#7	-17.08% Mar 1, 2023 - May 3, 2023	-24.13% Feb 26, 2007 - Aug 7, 2007
#8	-16.98% Aug 24, 2022 - Feb 13, 2023	-23.84% Dec 15, 2004 - Jun 30, 2005
#9	-11.44% Oct 15, 2021 - Nov 2, 2021	-20.05% Feb 3, 2026 - May 13, 2026
#10	-11.09% Dec 11, 2014 - Dec 29, 2014	-19.21% Sep 16, 2005 - Nov 29, 2005
#11	-9.36% Feb 13, 2023 - Mar 1, 2023	-13.18% Oct 31, 2007 - Dec 21, 2007
#12	-8.58% Jan 8, 2024 - Feb 8, 2024	-12.80% Aug 9, 2007 - Sep 27, 2007
#13	-8.27% Aug 10, 2022 - Aug 24, 2022	-12.41% Dec 22, 2005 - Jan 11, 2006
#14	-7.81% Jul 9, 2026 - Jul 23, 2026	-9.61% Jan 8, 2021 - Feb 1, 2021
#15	-6.08% Dec 29, 2014 - Jan 7, 2015	-9.15% Jun 13, 2017 - Sep 28, 2017